In our lab at Duke University we ideate, develop, and test digital behavioral health interventions for underserved populations, such as individuals who experience persistent mental health symptoms, addiction, or chronic pain. Our lab applies a variety of tools and methods, including group clinical trials methodology, single case experimental designs, user-centered design methods, and novel analytic tools for small N data. We are part of Duke’s Center for Addition Science and Technology, led by Dr. McClernon.
We specialize in (1) designing digital tools to foster the practice of psychological flexibility and mindfulness, and (2) the general application of a therapeutic approach called Acceptance and Commitment Therapy.
Our lab has received funding from the National Institute on Drug Abuse, Pfizer, The University of Washington Innovation Award, and the National Cancer Institute. Our lab is part of Duke’s Center for Addiction Science and Technology and we are located in Durham, North Carolina (US), in a 540 square foot space adjacent to Duke University.
vilardaga-lab at duke.edu
2812 Erwin Rd, Durham, NC 27705
Office Phone: 919-681-4798
- Testing novel approaches for smoking cessation in people with serious mental illness. The ‘Quit on the Go’ Trial (NCT03069482), is the first NIH funded smoking cessation trial testing mobile interventions in people serious mental illness (R00DA037276, PI: Vilardaga).
- Developing and testing novel interventions for people suffering with Chronic Pain. This project, funded by Pfizer, developed a digital intervention based on Acceptance and Commitment Therapy and is currently testing it in an open trial.
- Developing a novel framework for self-experimentation and healthcare delivery using agile methodologies (i.e., single case experimental designs) and novel analytic methods (i.e., randomization tests). This project was funded by the 2015 University of Washington Innovation Award.